MI Cancer Seek
Caris Life Sciences · Next generation sequencing oncology panel, somatic or germline variant detection system · Medical Genetics
Open FDA's page for this record- PMA number
- P240010
- Supplement number
- S007
- Applicant
- Caris Life Sciences
- Street 1
- 4610 S. 44th Pl.
- City
- Phoenix
- State
- AZ
- Zip
- 85040
- Generic name
- Next generation sequencing oncology panel, somatic or germline variant detection system
- Trade name
- MI Cancer Seek
- Product code
- PQP
- Advisory committee
- MG
- Advisory committee description
- Medical Genetics
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Expedited review flag
- N
- Date received
- 2025-11-26
- Decision date
- 2026-10-16
- Decision code
- APPR
- Ao statement
Approval for migration of the MI Cancer Seek (MCS) Bioinformatics Pipeline from an on-premises High-Performance Computing (HPC) cluster to Amazon Web Services (AWS) cloud infrastructure
- Harmonized identifiers (openFDA)
- Device name
- Next Generation Sequencing Oncology Panel, Somatic Or Germline Variant Detection System
- Medical specialty description
- Unknown
- Device class
- 3
- Registration number
- 3007287152, 3017020141, 3010679023, 3011104381, 3012090384, 3020703032, 3011805506, 3003335080, 3013200421, 3031598391, 3030654068, 3003218906, 3010889807
- FEI number
- 3016560486, 3007287152, 3010679023, 3011104381, 3012090384, 3008335090, 3011805506, 3003335080, 3013200421, 3031598391, 3030654068, 3003218906, 3010889807